William Lewis Insmed Inc (INSM) insider trading activity

William Lewis is Chair and CEO of INSMED Inc. Currently has a direct ownership of 384,125 shares of INSM, which is worth approximately $28.7 Million. The most recent transaction as insider was on May 14, 2024, when has been sold 22,198 shares (Common Stock) at a price of $25.52 per share, resulting in proceeds of $566,492. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 384K

0% 3M change

12.53% 12M change

Total Value Held $28.7 Million

William Lewis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 14 2024	SELL Open market or private sale	$566,492 $25.52 p/Share	22,198 Reduced 5.46%	384,125 Common Stock
May 13 2024	BUY Grant, award, or other acquisition	-	42,707 Added 9.51%	406,323 Common Stock
Jan 09 2024	SELL Open market or private sale	$283,954 $28.72 p/Share	9,887 Reduced 2.65%	363,651 Common Stock
Jan 08 2024	SELL Open market or private sale	$1,331,040 $29.5 p/Share	45,120 Reduced 10.78%	373,538 Common Stock
Jan 08 2024	BUY Exercise of conversion of derivative security	$924,508 $20.49 p/Share	45,120 Added 10.28%	393,707 Common Stock
Jan 05 2024	SELL Open market or private sale	$204,205 $29.26 p/Share	6,979 Reduced 1.83%	373,538 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	37,869 Added 9.05%	380,517 Common Stock
May 17 2023	SELL Open market or private sale	$128,633 $18.12 p/Share	7,099 Reduced 2.04%	341,345 Common Stock
May 16 2023	SELL Open market or private sale	$68,374 $18.41 p/Share	3,714 Reduced 1.05%	348,444 Common Stock
May 15 2023	SELL Open market or private sale	$116,303 $19.23 p/Share	6,048 Reduced 1.69%	352,158 Common Stock
May 11 2023	BUY Grant, award, or other acquisition	-	93,139 Added 20.64%	358,206 Common Stock
Jan 10 2023	SELL Open market or private sale	$125,892 $18.0 p/Share	6,994 Reduced 2.57%	265,067 Common Stock
Jan 05 2023	SELL Open market or private sale	$138,758 $19.8 p/Share	7,008 Reduced 2.73%	249,708 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	22,353 Added 7.59%	272,061 Common Stock
Jul 07 2022	SELL Open market or private sale	$2,222,122 $23.0 p/Share	96,614 Reduced 27.34%	256,716 Common Stock
Jul 07 2022	BUY Exercise of conversion of derivative security	$1,561,282 $16.16 p/Share	96,614 Added 21.47%	353,330 Common Stock
May 17 2022	SELL Open market or private sale	$120,999 $20.18 p/Share	5,996 Reduced 2.29%	255,828 Common Stock
May 16 2022	SELL Open market or private sale	$62,353 $18.35 p/Share	3,398 Reduced 1.28%	261,824 Common Stock
May 11 2022	BUY Grant, award, or other acquisition	-	47,598 Added 15.22%	265,222 Common Stock
Mar 23 2022	SELL Open market or private sale	$2,252,072 $23.31 p/Share	96,614 Reduced 30.75%	217,624 Common Stock
Mar 23 2022	BUY Exercise of conversion of derivative security	$1,499,449 $15.52 p/Share	96,614 Added 30.65%	218,605 Common Stock
Jan 11 2022	SELL Open market or private sale	$72,141 $25.11 p/Share	2,873 Reduced 1.3%	217,624 Common Stock
Jan 06 2022	SELL Open market or private sale	$138,762 $26.0 p/Share	5,337 Reduced 2.74%	189,756 Common Stock
Jan 06 2022	BUY Grant, award, or other acquisition	-	30,741 Added 12.24%	220,497 Common Stock
Jan 05 2022	SELL Open market or private sale	$196,749 $27.61 p/Share	7,126 Reduced 3.52%	195,093 Common Stock

Also insider at

NAMS

NewAmsterdam Pharma Co N.V.

William Lewis

Chair and CEO

Bridgewater, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INSM shares.

Notify only if

Value

Insider Trading

Get notified when an Insmed Inc insider buys or sells INSM shares.

Notify only if

Operation

Value

Type

News

Receive news related to INSMED Inc

Track Activities on INSM

Account